IRCT20210614051574N3尚未招募2 期
The effect of pioglitazone on the improvement of non-alcoholic fatty liver in obese patients
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 入组人数
- 44
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 65 years（—）
- 性别
- All
入选标准
- •Age between 18 and 65 years
- •Candidate for bariatric surgery
- •Non-alcoholic fatty liver disease grade 3
- •Satisfaction with inclusion in the study
排除标准
- •Daily consumption of more than 40 grams and 20 grams of alcohol for men and women, respectively
- •Having other liver diseases
- •Liver cancer
- •Taking hepatotoxic drugs
研究者
相似试验
招募中
3 期
Evaluation of Effect of pioglitazone on decreasing of proteinuria in type II diabetic patients with nephropathy.Diabetic Nephropathy.E10.2Insulin-deIRCT2017080210222N10Vice chancellor for research of Shahrekord University of Medical Science60
招募中
不适用
The effect of pioglitazone on reducing opioid and heroin dependence.IRCT20190427043389N2Zanjan University of Medical Sciences100
已完成
2 期
Pioglitazone the treatment of schizophreniaschizophrenia.schizophreniaIRCT201110281556N30Tehran University of Medical Sciences30
进行中（未招募）
不适用
Effect of pioglitazone in patienst with Adrenomyeloneuropathy.X-linked adrenoleukodystrophyEUCTR2011-006113-34-ESAURORA PUJOL ONOFRE
招募中
3 期
Effect of Pioglitazone and ClobetasolIRCT20210926052596N1Tehran University of Medical Sciences40